نتایج جستجو برای: dr5

تعداد نتایج: 1346  

2007
JUNJI KOUHARA TATSUSHI YOSHIDA SUSUMU NAKATA MANO HORINAKA MIKI WAKADA YUJI UEDA HISAKAZU YAMAGISHI TOSHIYUKI SAKAI

Fenretinide (N-[4-Hydroxyphenyl]retinamide; 4HPR) is a semisynthetic retinoid that induces apoptosis in a variety of malignancies. Fenretinide has been examined in clinical trials as a cancer chemopreventive and chemotherapeutic agent. Oxidative stress induced by fenretinide has been shown to mediate apoptosis through a mitochondrial pathway by the induction of a transcription factor CCAAT/ enh...

2005
Jeffrey Martin

There are several tumor necrosis factor proteins (TNF) responsible for signaling cell death (TNF-R1, DR3, DR4, DR5, and DR6). The binding of TNF related apoptosis-inducing ligand (TRAIL) to some of these receptors initiates the cell death pathway and causes apoptosis. TRAIL is a homotrimer which binds three like death receptors (Figure 1). This leads to trimerization of the death receptors and ...

Journal: :Human reproduction 2009
Akiko Hasegawa Yutaka Osuga Yasushi Hirota Kahori Hamasaki Ako Kodama Miyuki Harada Toshiki Tajima Yuri Takemura Tetsuya Hirata Osamu Yoshino Kaori Koga Tetsu Yano Yuji Taketani

BACKGROUND The increase in concentration of osteoprotegerin, an antagonist of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), in the peritoneal fluid of women with endometriosis may interfere with TRAIL-induced apoptosis in endometriotic cells and promote the development of endometriosis. In the present study, the effect of tunicamycin, a possible apoptosis enhancer, on TRAIL-i...

Journal: :Molecular cancer therapeutics 2010
Dong-Oh Moon Mun-Ock Kim Yung Hyun Choi Gi-Young Kim

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces cell death in various types of cancer cells but has little or no effect on normal cells. Human hepatoma cells are resistant to TRAIL-induced apoptosis. Although butein is known to mediate anticancer, anti-inflammatory, and antioxidant activities, little is known about the mechanism of butein in terms of TRAIL-induced apopto...

Journal: :Development 1998
D Huang S W Chen A W Langston L J Gudas

The murine Hoxb-1 gene contains a homeobox sequence and is expressed in a spatiotemporal specific pattern in neuroectoderm, mesoderm and gut endoderm during development. We previously identified a conserved retinoic acid (RA)-inducible enhancer, named the RAIDR5, which contains a DR5 RARE; this RAIDR5 enhancer is located 3' of the Hoxb-1-coding region in both the mouse and chick. In the F9 muri...

Journal: :Infection and immunity 2010
Moo-Seung Lee Rama P Cherla Erin K Lentz Dinorah Leyva-Illades Vernon L Tesh

Shiga toxins (Stxs) induce apoptosis via activation of the intrinsic and extrinsic pathways in many cell types. Toxin-mediated activation of the endoplasmic reticulum (ER) stress response was shown to be instrumental in initiating apoptosis in THP-1 myeloid leukemia cells. THP-1 cells responded to Shiga toxin type 1 (Stx1) in a cell maturation-dependent manner, undergoing rapid apoptosis in the...

Journal: :Journal of immunology 2014
Ali R Jazirehi Siavash K Kurdistani James S Economou

Modern immune therapies (PD-1/PD-L1 and CTLA-4 checkpoints blockade and adoptive cell transfer) have remarkably improved the response rates of metastatic melanoma. These modalities rely on the killing potential of CTL as proximal mediator of antimelanoma responses. Mechanisms of tumor resistance to and the predominant cytotoxic pathway(s) used by melanoma-reactive CTL are important outcome dete...

Journal: :Molecular cancer therapeutics 2007
Hyunki Kim Tandra R Chaudhuri Donald J Buchsbaum Deli Wang Kurt R Zinn

A murine, apoptosis-inducing monoclonal antibody (mTRA-8) targeting human DR5 was radiolabeled with Tc-99m. The binding affinity (K(d)) and the number of DR5 receptors were measured in MD MBA-231-derived 2LMP cell lines that were "sensitive" or "resistant" to mTRA-8 killing. Single-photon emission computed tomography and X-ray computed tomography (SPECT/CT) evaluated the Tc-99m-mTRA-8 retention...

2015
Anupama Reddy Joseph D. Growney Nick S. Wilson Caroline M. Emery Jennifer A. Johnson Rebecca Ward Kelli A. Monaco Joshua Korn John E. Monahan Mark D. Stump Felipa A. Mapa Christopher J. Wilson Janine Steiger Jebediah Ledell Richard J. Rickles Vic E. Myer Seth A. Ettenberg Robert Schlegel William R. Sellers Heather A. Huet Joseph Lehár Surinder K. Batra

Death Receptor 5 (DR5) agonists demonstrate anti-tumor activity in preclinical models but have yet to demonstrate robust clinical responses. A key limitation may be the lack of patient selection strategies to identify those most likely to respond to treatment. To overcome this limitation, we screened a DR5 agonist Nanobody across >600 cell lines representing 21 tumor lineages and assessed molec...

Journal: :The Journal of biological chemistry 2001
E R McDonald P C Chui P F Martelli D T Dicker W S El-Deiry

The Fas/tumor necrosis factor (TNF)/TRAIL receptors signal death through a cytoplasmic death domain (DD) containing six alpha-helices with positively charged helix 2 interacting with negatively charged helix 3 of another DD. DD mutation occurs in head/neck and lung cancer (TRAIL receptor KILLER/DR5) and in lpr mice (Fas). We examined the apoptotic potential of known KILLER/DR5 lung tumor-derive...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید